Important information for providers and patients to prevent sub-therapeutic dosing of levothyroxine.
The FDA has upgraded an alert on levothyroxine tablets made by a specific manufacturer to a class II alert.
Please visit the links below for more information.
FDA Upgrades Recall on 160,000+ Bottles of Thyroid Medication
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.